, Primers were as follows: mouse Ifnc 5 0-CAACAGCAAGGCGAAAAAGG-3 0 and 5 0CCTGTGGGTTGTTGACCTCAA-3 0 , mouse Gzmb, the QuantiTect reverse transcription kit (QIAGEN), and the cDNA was analyzed by realtime PCR using the SYBR Premix Ex Taq (Takara)

L. Chiossone, J. Chaix, N. Fuseri, C. Roth, E. Vivier et al., Maturation of mouse NK cells is a 4-stage developmental program, Blood, vol.113, pp.5488-5496, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00407779

D. Santo, J. P. Vosshenrich, and C. A. , Bone marrow versus thymic pathways of natural killer cell development, Immunol Rev, vol.214, pp.35-46, 2006.

S. Dong, B. Corre, E. Foulon, E. Dufour, A. Veillette et al., T cell receptor for antigen induces linker for activation of T cell-dependent activation of a negative signaling complex involving Dok2, SHIP-1, and Grb-2, J Exp Med, vol.203, pp.2509-2518, 2006.
URL : https://hal.archives-ouvertes.fr/pasteur-00162042

G. Firaguay and J. A. Nunes, Analysis of signaling events by dynamic phosphoflow cytometry, Sci Signal, vol.2, p.3, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00408711

A. Gerard, C. Favre, F. Garcon, J. G. Nemorin, P. Duplay et al., Functional interaction of RasGAP-binding proteins Dok1 and Dok2 with the Tec protein tyrosine kinase, Oncogene, vol.23, pp.1594-1598, 2004.

A. Gerard, M. Ghiotto, C. Fos, G. Guittard, D. Compagno et al., Dok4 is a novel negative regulator of T cell activation, J Immunol, vol.182, pp.7681-7689, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00374930

G. Guittard, A. Gerard, S. Dupuis-coronas, H. Tronchere, E. Mortier et al., Cutting edge: Dok1 and Dok2 adaptor molecules are regulated by phosphatidylinositol 5-phosphate production in T cells, J Immunol, vol.182, pp.3974-3978, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00364224

Y. Hayakawa and M. J. Smyth, CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity, J Immunol, vol.176, pp.1517-1524, 2006.

A. Inoue, T. Yasuda, T. Yamamoto, and Y. Yamanashi, Dok1 is a positive regulator of IL-4 signalling and IgE response, J Biochem, vol.142, pp.257-263, 2007.

S. Kim, K. Iizuka, H. S. Kang, A. Dokun, A. R. French et al., In vivo developmental stages in murine natural killer cell maturation, Nat Immunol, vol.3, pp.523-528, 2002.

E. Le-drean, F. Vely, L. Olcese, A. Cambiaggi, S. Guia et al., Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases, Eur J Immunol, vol.28, pp.264-276, 1998.

C. M. Lee, I. D. Jung, K. T. Noh, J. S. Lee, J. W. Park et al., An essential regulatory role of downstream of kinase-1 in the ovalbumin-induced murine model of asthma, PLoS ONE, vol.7, p.34554, 2012.

D. Liu, M. E. Peterson, and E. O. Long, The adaptor protein Crk controls activation and inhibition of natural killer cells, Immunity, vol.36, pp.600-611, 2012.

H. G. Ljunggren and K. J. Malmberg, Prospects for the use of NK cells in immunotherapy of human cancer, Nat Rev Immunol, vol.7, pp.329-339, 2007.

J. Loh, D. T. Chu, A. K. O'guin, W. M. Yokoyama, and V. Hwt, Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver, J Virol, vol.79, pp.661-667, 2005.

E. O. Long, H. S. Kim, D. Liu, M. E. Peterson, and S. Rajagopalan, Controlling natural killer cell responses: integration of signals for activation and inhibition, Annu Rev Immunol, vol.31, pp.227-258, 2013.

R. Mashima, Y. Hishida, T. Tezuka, and Y. Yamanashi, The roles of Dok family adapters in immunoreceptor signaling, Immunol Rev, vol.232, pp.273-285, 2009.

N. Messal, E. Mamessier, A. Sylvain, J. Celis-gutierrez, M. L. Thibult et al., Differential role for CD277 as a co-regulator of the immune signal in T and NK cells, Eur J Immunol, vol.41, pp.3443-3454, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00620920

A. Miletic, A. Krmpotic, and S. Jonjic, The evolutionary arms race between NK cells and viruses: who gets the short end of the stick?, Eur J Immunol, vol.43, pp.867-877, 2013.

E. Narni-mancinelli, J. Chaix, A. Fenis, Y. M. Kerdiles, N. Yessaad et al., Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor, Proc Natl Acad Sci, vol.108, pp.18324-18329, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00672199

J. G. Nemorin, P. Laporte, G. Berube, and P. Duplay, p62dok negatively regulates CD2 signaling in Jurkat cells, J Immunol, vol.166, pp.4408-4415, 2001.

M. Niki, D. Cristofano, A. Zhao, M. Honda, H. Hirai et al., Role of Dok1 and Dok2 in leukemia suppression, J Exp Med, vol.200, pp.1689-1695, 2004.

J. A. Nunes, A. Truneh, D. Olive, and D. A. Cantrell, Signal transduction by CD28 costimulatory receptor on T cells. B7-1 and B7-2 regulation of tyrosine kinase adaptor molecules, J Biol Chem, vol.271, pp.1591-1598, 1996.

M. T. Orr and L. L. Lanier, Natural killer cell education and tolerance, Cell, vol.142, pp.847-856, 2010.
DOI : 10.1016/j.cell.2010.08.031

URL : https://doi.org/10.1016/j.cell.2010.08.031

I. Slavuljica, A. Busche, M. Babic, M. Mitrovic, I. Gasparovic et al., Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties, J Clin Invest, vol.120, pp.4532-4545, 2010.
DOI : 10.1172/jci43961

URL : http://www.jci.org/articles/view/43961/files/pdf

H. R. Smith, J. W. Heusel, I. K. Mehta, S. Kim, B. G. Dorner et al., Recognition of a virus-encoded ligand by a natural killer cell activation receptor, Proc Natl Acad Sci, vol.99, pp.8826-8831, 2002.
DOI : 10.1073/pnas.092258599

URL : http://www.pnas.org/content/99/13/8826.full.pdf

N. Vey, J. H. Bourhis, N. Boissel, D. Bordessoule, T. Prebet et al., A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission, Blood, vol.120, pp.4317-4323, 2012.

E. Vivier, J. A. Nunes, and F. Vely, Natural killer cell signaling pathways, Science, vol.306, pp.1517-1519, 2004.
DOI : 10.1126/science.1103478

URL : https://hal.archives-ouvertes.fr/hal-00080580

E. Vivier, S. Ugolini, D. Blaise, C. Chabannon, and L. Brossay, Targeting natural killer cells and natural killer T cells in cancer, Nat Rev Immunol, vol.12, pp.239-252, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00685473

E. Vivier, S. Ugolini, and J. A. Nunes, ADAPted secretion of cytokines in NK cells, Nat Immunol, vol.14, pp.1108-1110, 2013.
DOI : 10.1038/ni.2737

URL : https://hal.archives-ouvertes.fr/inserm-01038082

M. Yagita, C. L. Huang, H. Umehara, Y. Matsuo, R. Tabata et al., A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation, Leukemia, vol.14, pp.922-930, 2000.
DOI : 10.1038/sj.leu.2401769

URL : https://www.nature.com/articles/2401769.pdf

Y. Yarkoni, A. Getahun, and J. C. Cambier, Molecular underpinning of B-cell anergy, Immunol Rev, vol.237, pp.249-263, 2010.
DOI : 10.1111/j.1600-065x.2010.00936.x

URL : http://europepmc.org/articles/pmc2968701?pdf=render

T. Yasuda, K. Bundo, A. Hino, K. Honda, A. Inoue et al., Dok1 and Dok2 are negative regulators of T cell receptor signaling, Int Immunol, vol.19, pp.487-495, 2007.
DOI : 10.1093/intimm/dxm015

URL : https://academic.oup.com/intimm/article-pdf/19/4/487/2031436/dxm015.pdf

L. Zitvogel, L. Apetoh, F. Ghiringhelli, and G. Kroemer, Immunological aspects of cancer chemotherapy, Nat Rev Immunol, vol.8, pp.59-73, 2008.